Related Experiment Video
Updated: Mar 22, 2026

07:31
In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye
Published on: October 8, 2017
9.5K
Long-Term Tracking Mesenchymal Stem Cell Differentiation with Photostable Fluorescent Nanoparticles
Shiying Liu1, Li Min Tay1,2, Raditya Anggara1
1School of Chemical and Biomedical Engineering, Nanyang Technological University , 62 Nanyang Drive, Singapore 637459, Singapore.
ACS Applied Materials & Interfaces
|April 29, 2016
Summary
New PCL-DPP-PCL nanoparticles enable long-term tracking of mesenchymal stem cells (MSCs) for regenerative medicine. While effective for adipogenic and chondrogenic differentiation, they inhibit osteogenic potential.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Cell Biology
Background:
- Mesenchymal stem cells (MSCs) are vital for tissue repair but tracking their fate post-transplantation remains challenging.
- Current cell tracking methods lack long-term stability and can impact cell function.
- Developing biocompatible, photostable probes is crucial for monitoring MSCs in regenerative therapies.
Purpose of the Study:
- To evaluate the efficacy of novel PCL-DPP-PCL nanoparticles for labeling and long-term tracking of MSCs.
- To assess the impact of PCL-DPP-PCL nanoparticle labeling on MSC viability, proliferation, and multilineage differentiation potential.
- To determine the photostability and retention of fluorescence from PCL-DPP-PCL nanoparticles in labeled MSCs.
Main Methods:
- Synthesis of PCL-DPP-PCL polymer complex nanoparticles.
- Labeling of MSCs with PCL-DPP-PCL nanoparticles.
- Assessment of MSC viability and proliferation post-labeling.
- In vitro multilineage differentiation assays (osteogenic, adipogenic, chondrogenic) with gene expression and histological analysis.
- Long-term fluorescence imaging to evaluate nanoparticle retention.
Main Results:
- PCL-DPP-PCL nanoparticles did not affect MSC viability or proliferation.
- Labeled MSCs showed normal adipogenic and chondrogenic differentiation compared to controls.
- Osteogenic differentiation of labeled MSCs was significantly inhibited.
- Strong fluorescence was retained in PCL-DPP-PCL labeled MSCs for over 4 weeks.
Conclusions:
- PCL-DPP-PCL nanoparticles are suitable for long-term tracking of MSCs, particularly for adipogenic and chondrogenic differentiation.
- The inhibitory effect on osteogenic differentiation needs consideration for specific therapeutic applications.
- These nanoparticles offer a promising tool for monitoring MSC behavior in regenerative medicine research.

